当前位置: 首页 > 期刊 > 《新英格兰医药杂志》 > 2004年第9期 > 正文
编号:11307514
Early Malignant Progression of Hereditary Medullary Thyroid Cancer
http://www.100md.com 《新英格兰医药杂志》
     To the Editor: I wish to point out that our report on early malignant progression of hereditary medullary thyroid cancer (Oct. 16 issue)1 contains a description of clinical material from 50 patients, of the 207 patients overall, that was also included in an article previously published in Surgery.2 Although asked to do so, we failed to inform the editors of each journal of the publication of these data in the other journal. We apologize for not having provided this information earlier.

    Andreas Machens, M.D.

    Martin-Luther-Universit?t Halle-Wittenberg

    D-06097 Halle (Saale), Germany

    gensurg@medzin.uni-halle.de

    References

    Machens A, Niccoli-Sire P, Hoegel J, et al. Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 2003;349:1517-1525.

    Machens A, Holzhausen HJ, Thanh PN, Dralle H. Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery 2003;134:425-431.